We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mercia Asset Management Plc | LSE:MERC | London | Ordinary Share | GB00BSL71W47 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.50 | 29.00 | 30.00 | 29.50 | 29.50 | 29.50 | 52,058 | 07:32:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 25.88M | 2.84M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/5/2020 10:08 | Hidden value and it will stay largely hidden until it’s realised, hence the buying opportunity, but always DYOR. | gwr7 | |
06/5/2020 09:23 | how are they getting on with their stakes in Impression, medherant and nDreams, i wonder? | mw8156 | |
06/5/2020 09:11 | Oxgene doubling revenues Collaboration with Native Antigen MERC with 30%in both (maybe more now for Oxgene) | mr.oz | |
06/5/2020 09:10 | Yes, good that they're talking about investing for the medium to long term for this fast growing company. Also good that Canaccord are involved as Mercia's large stake could have put other instis off. | gwr7 | |
06/5/2020 08:40 | Excellent Indeed andyview Mercia Asset Management PLC @Mercia_PLC ยท 50m Mercia invests £1.0million as part of a £3.0million syndicated investment into OXGENE. Read the full details including comments from @MPayton_Mercia Mark Payton - Mercia Asset Management here - | cheshire man | |
06/5/2020 08:28 | I’ve decided to add a few more, MERC have provided £1 mill of the new funding totalling £3 mill. Liked this it too: OXGENE™ has worked with global partners including Abcam plc for the delivery of over 1,000 CRISPR engineered cell lines, Artios Pharma, who are developing breakthrough cancer treatments, and The Native Antigen Company (also a Mercia direct investment) to accelerate the production of COVID-19 antigens. Gla | andyview | |
06/5/2020 08:16 | More excellent news out today, gla | andyview | |
04/5/2020 15:06 | NAC :quite a shining star for MERC. Will be very interested in how their value is growing | mr.oz | |
04/5/2020 12:50 | I think the interaction between Concepta and Abingdon shows the benefit of Mercia’s involvement in both companies. | gwr7 | |
04/5/2020 10:23 | Indeed, every positive ingredient/developme I note also that another Mercia portfolio company, MIP Diagnostics, has entered into a COVID-19 testing collaboration - Stream Bio collaborates with MIP Diagnostics Ltd. on a rapid diagnostic and mass screening test for COVID-19 | wan | |
04/5/2020 08:51 | All grist to the mill. Concepta have a licence to use Abingdon's app so Abingdon will get a royalty from Concepta sales. | gwr7 | |
04/5/2020 08:22 | I think this is intriguing And ambitious | mr.oz | |
04/5/2020 07:20 | According to today's news, Abigndon Health find Concepta and the Femtech opportunity interesting enough to enter into a partnership - Concepta PLC Partnership agreement with Abingdon Health 04/05/2020 7:00am RNS Non-Regulatory | wan | |
03/5/2020 22:16 | Concepta are outsourcing manufacturing to Abingdon Health. The latter will gain from manufacturing capacity that wasn't being utilised. I don't think Concepta is one of the more interesting companies in Mercia's portfolio. | gwr7 | |
02/5/2020 09:06 | Recently Mercia supported and took part in a placing for Concepta at 0.08p. Concepta are indirectly connected with recent Coronavirus developments at Abingdon Health. I note that there has since been a spike in volumes and an increase in Concepta's share price, and yesterday the shares jumped over 30% on strong volume and no news! | wan | |
01/5/2020 14:07 | I’ve added a few more, solid investment case imho Gla | andyview | |
01/5/2020 11:45 | Thanks GWR! Still practicing in the garden, that Dabizas turn still works, and my son is picking up the reins Good info, cheers, D | dennisbergkamp | |
01/5/2020 11:29 | We've signed the best player I've seen in the premiership now. Nice one Dennis. I'm not expecting fireworks but we have strong asset backing and I do expect a re-rating. The covid companies will establish the business model and set us up for years. They're looking to be evergreen by 2022 ie. new direct portfolio buys and existing company development funding rounds are covered by value realisation, either by IPO or company sales. | gwr7 | |
01/5/2020 10:33 | Looks very interesting as an indirect way to cover a number of companies helping the cause D | dennisbergkamp | |
01/5/2020 10:06 | Also, Abingdon Healthcare are a partner in the RTC with Omega. | longshanks | |
01/5/2020 08:30 | Apologies if I didn't make the connection with Omega clear. MERC have a significant holding in The Native Antigen Company who are making reagents for use in the antibody test being developed by Omega and the British consortium partners. Both Omega and the NAC will gain big time from the approval of the test anticipated in June/July. There has been some positive news in the last 24 hours. Oxford University's Professor John Bell, who led the assessment of imported tests that were shown to be innacurate, gave a positive update on channel 4 news saying the British consortium was world leading. Also ODX have moved quickly to expand their premises. | gwr7 | |
01/5/2020 08:09 | Anyone got an idea of how omega holding likely to affect current nav given its rise? | its the oxman | |
30/4/2020 16:33 | Approx £50k mopped up at the close of play | mr.oz | |
30/4/2020 12:18 | My pleasure Mr Richardson. Like longshanks I know a bit about Omega. I’m convinced the consortium will produce an antibody test though nobody can say when and the government was late getting the ball rolling. Development started in April when it could easily have been February. We know from experience that it can take years to achieve a fully approved POC test. A lot of that is tortuous regulatory hurdles which now vanish like the morning mist when the government has a crisis on it’s hands and they’re aiming to produce the test in June/July. One of the positives that will come out of this is more focus on diagnostics in the UK which will benefit the whole sector. It’s been a crying shame and all the delays have caused unnecessary death but by investing in the companies involved, rather than trading, we are making a difference. I could pull out of Omega now with a 500% gain but I’m holding after covering my initial purchase. Once we get the POC test it will be a boost for MERC. I don’t even think it needs to be a consortium test as the high tech manufacturers will still be involved due to the numbers required. I’d prefer it to be an entirely Made in Britain test though. Goodness knows we deserve it. | gwr7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions